CASI PHARMACEUTICALS, INC. Deferred Tax Assets, Investments
CASI PHARMACEUTICALS, INC. (CASIF) had Deferred Tax Assets, Investments of $877.00 thousand as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestments · last filed 2026-05-15
- 2025-12-31: Deferred Tax Assets, Investments $877.00K.
- 2024-12-31: Deferred Tax Assets, Investments $326.00K.
- 2023-12-31: Deferred Tax Assets, Investments $870.00K.
- 2022-12-31: Deferred Tax Assets, Investments $1.48M.
| Period end | Deferred Tax Assets, Investments |
|---|---|
| 2025-12-31 | $877.00K 20-F · filed 2026-05-15 |
| 2024-12-31 | $326.00K 20-F · filed 2026-05-15 |
| 2023-12-31 | $870.00K 20-F · filed 2025-03-31 |
| 2022-12-31 | $1.48M 20-F · filed 2024-03-28 |